Overview of Flucold
What is Flucold? Definition and Pharmaceutical Type
| Property | Description |
|---|---|
| Active Ingredients | Acetaminophen (Paracetamol), Chlorphenamine |
| Form | Solid Oral Preparation (e.g., Tablet or Capsule) |
| Pharmacological Class | Non-Opioid Analgesic, Antipyretic, Antihistamine |
| Common Use | Multi-symptom relief for respiratory/allergic discomfort |
| Origin | Synthetically Derived Compounds |
Flucold is structurally defined as a fixed-dose combination product intended for systemic use, typically administered as a solid oral preparation such as a tablet or capsule. This preparation represents a single medication entity that combines multiple pharmacological actions, contrasting with single-ingredient medications that target only one symptom pathway. The combination is designed to deliver simultaneous therapeutic effects via the oral route of administration, providing comprehensive symptomatic coverage in one format, consistent with the standard definition of combination oral cold preparations.
The Active Components and Pharmacological Classification
The core composition of Flucold includes the synthetically derived active ingredients Acetaminophen (Paracetamol) and Chlorphenamine (Chlorpheniramine). Acetaminophen is clinically recognized for its analgesic and antipyretic efficacy. It is classified as a non-opioid analgesic and antipyretic, meaning it acts to relieve general pain and reduce fever. Chlorphenamine is classified as a first-generation antihistamine, a compound that specifically works to block the effects of histamine. This specific two-component formulation differentiates it from more complex cold remedies that may include a third agent, positioning Flucold for patients whose primary need is to manage pain/fever and allergic rhinitis symptoms.
General Purpose: Dual-Action Symptom Relief
The general purpose of Flucold is to achieve multi-symptom relief by engaging two distinct physiological pathways at once. A typical use scenario involves managing the discomfort experienced during the onset of a common cold or allergic reaction. It helps manage malaise by reducing elevated body temperature and dampening the perception of minor aches through the analgesic component. Concurrently, the antihistamine component serves to suppress allergic responses, addressing symptoms like sneezing, itchy eyes, and runny nose. This dual-action design provides a practical way to manage the overlapping signs of general discomfort and allergic manifestations often associated with respiratory illness.
Regulatory References

